Infinity Pharmaceuticals | INFI - Операционный доход





Операционный доход Изменить Дата
AbbVie USD 4.73B 1.08B 2026-03
Alterity Therapeutics Limited AUD -8.07M 302.4K 2025-12
Amgen USD 3.83B 130M 2026-03
AstraZeneca USD 7.11B 4.14B 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
Cipla INR 9.77B 6.21B 2025-12
Clal Biotechnology ILS -1.74M 7.46M 2022-12
Compugen USD 56.04M 63.93M 2025-12
CSL USD 2.64B 1.97B 2025-12
Eisai JPY 20.03B 6.36B 2025-12
Eli Lilly USD 9.78B 792M 2026-03
Gilead Sciences USD 2.68B 284M 2026-03
GlaxoSmithKline GBP 2.29B 856M 2026-03
Grifols EUR 320.55M 91.01M 2025-12
Incyte USD 324.17M 59.7M 2026-03
Infinity Pharmaceuticals USD -10.12M 1.39M 2023-06
Ionis Pharmaceuticals USD -118M 97M 2026-03
J&J USD 6.62B 1.03B 2026-03
Novartis USD 4.24B 171M 2026-03
Pfizer USD 4.99B 340M 2026-03
Plus Therapeutics USD -5.74M 1.26M 2025-12
Roche Holding CHF 9.56B 3.8B 2025-12
TG Therapeutics USD 34.8M 15.7M 2026-03